Answers are grounded in this paper and cite their sources.
BACKGROUND: This study aimed to introduce a first-cycle β-hCG response marker for predicting first-line single-agent chemoresistance in low-risk gestational trophoblastic neoplasia (GTN). METHODS: This retrospective study included 299 patients. Patients were randomly assigned to a development cohort (n = 198) and internal validation cohort (n = 101). The primary exposure was the C2/C1 β-hCG ratio, defined as the serum β-hCG level before cycle 2 divided by the level before cycle 1. Restricted cubic spline and receiver operating characteristic analyses were used to derive the optimal threshold. Three models were evaluated: a FIGO-only model, a baseline clinical model, and a first-cycle dynamic model incorporating the C2/C1 ratio. RESULTS: First-line single-agent chemoresistance occurred in 45 patients in the development cohort and 23 in the internal validation cohort. The optimal C2/C1 β-hCG threshold was 0.38. Patients with a poor first-cycle response had higher chemoresistance rates than favorable responders in both the development cohort (43.8% vs. 8.5%) and internal validation cohort (44.7% vs. 9.5%). The dynamic model showed superior discrimination compared with the baseline clinical model, with AUCs of 0.867 in the development cohort and 0.844 in the internal validation cohort. Addition of the C2/C1 ratio improved calibration, reduced Brier scores, and yielded significant reclassification improvement. Poor responders required more cycles to β-hCG normalization, more total chemotherapy cycles, and more frequent second-line or multi-agent therapy. CONCLUSIONS: The first-cycle C2/C1 β-hCG ratio showed potential for predicting first-line single-agent chemoresistance in low-risk GTN. A threshold of 0.38 may help identify patients requiring closer monitoring, but requires prospective multicenter validation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: